In February 2010, a quadrivalent conjugate vaccine (Menveo; Novartis Vaccines and Diagnostics) was approved by the US FDA to prevent invasive meningococcal disease caused by Neisseria meningitidis ...
LONDON, GREATER LONDON, UNITED KINGDOM, March 10, 2025 /EINPresswire / -- How Has the Menveo Market Performed in Recent Years, and What Does Its Future Hold? The Menveo market has experienced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback